Interaction between metabolic health and healthy aging supported
New findings on the role of RNA Polymerase I in longevity and metabolic health - excessive protein intake shortens lifespan - connection between energy metabolism and cancer risk. The study brought together the expertise in organismal and cellular metabolism and aging of Maria Ermolaeva’s research group "Stress Tolerance and Homeostasis" at the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) in Jena, and the experience in Pol I transcription and ribosome biogenesis of Holger Bierhoff’s research group "Epigenetics of Aging" which is affiliated with the Friedrich Schiller University Jena and also associated with the FLI.
Jena. Ribosomes, the "translation factories" of the cell, are cellular organelles that play a central role in protein synthesis, a vital process for all living organisms. These tiny structures themselves consist of ribonucleic acid (RNA) and proteins and are essential for the survival and normal functioning of the cell, as the proteins they produce are required for nearly all cellular processes, including structure, function, and regulation.
The production of ribosomes begins when RNA polymerase I (Pol I) synthesizes pre-rRNA, a precursor transcript of the mature ribosomal RNA (rRNA) that later becomes part of the ribosome. Previously, it was shown that lower activity of Pol I is associated with longer life, but there was no precise explanation for this. A study published in “Nature Communications” now demonstrates that reducing Pol I activity in the nematode Caenorhabditis elegans leads to improved mitochondrial function and a more stable metabolism, thereby extending lifespan. These findings also have implications for human aging.
The study brought together the expertise in organismal and cellular metabolism and aging of Maria Ermolaeva’s research group "Stress Tolerance and Homeostasis" at the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) in Jena, and the experience in Pol I transcription and ribosome biogenesis of Holger Bierhoff’s research group "Epigenetics of Aging" which is affiliated with the Friedrich Schiller University Jena and also associated with the FLI.
rRNA biosynthesis and ribosome biogenesis collectively consume up to 60% of the cellular energy. In this context, the research team's findings support the idea that Pol I inhibition extends lifespan, healthy lifespan, and metabolic fitness by actively lowering energy consumption. Interestingly, reduction of Pol I activity not only generates an ATP surplus that can be used by cellular quality control pathways, but also elicits metabolic rewiring to curb triglyceride expenditure and mitochondrial respiration. Because mitochondrial respiration is a key source of reactive oxygen species (ROS) and mitochondrial damage during aging, the reduction of this activity confers an anti-aging effect. The researchers also genetically modified C. elegans to increase Pol I activity.
While these animals demonstrated early advantage in fitness showing increased body size and neuromuscular performance, their metabolism deteriorated more quickly, leading to premature aging and early death. Finally, it was shown that the life-extending capacity of reduced Pol I activity is not limited by aging and elicits benefits also in late life. “It was very exciting for us to discover a longevity intervention that is effective in late life because previous work by us and others determined old age to be a limiting factor for the efficacy of commonly known interventions such as metformin and dietary restriction,” says Maria Ermolaeva. “It was also exciting to discover a geroprotective intervention that acts by actively suppressing energy metabolism. Studies in very long-lived species like bowhead whale and naked mole rat found reduced energy metabolism among their key genetic advantages. Now we uncovered an intervention that can potentially replicate this positive trait in humans”.
Since the researchers also included human cells in their studies, the findings might be also relevant for human aging. “Aging is the major risk factor for developing cancer, which in turn is almost always associated with elevated ribosome biogenesis” says Holger Bierhoff. “A moderate reduction of rRNA synthesis, especially at old age, may be a viable option not only to improve metabolic health, but also to reduce the cancer risk” he adds. Finally, the study highlights that excessive dietary protein intake - a common self-intervention that facilitates muscle growth in combination with strength exercise - bears potential risks, because it also stimulates Pol I activity. Akin to the findings in Pol I-enhanced nematodes, the overconsumption of protein-rich foods and supplements may improve physical fitness in the short-term, but may accelerate the metabolic aging process in the long-term, potentially impeding organ function in late life.
The study provides important insights into the molecular mechanisms underlying longevity. Targeted regulation of Pol I activity could potentially open up new avenues for the development of therapies to promote healthy aging.
The Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) – upon its inauguration in 2004 – was the first German research organization dedicated to research on the process of aging. Around 350 employees from around 40 nations explore the molecular mechanisms underlying aging processes and age-associated diseases. For more information, please visit www.leibniz-fli.de.
The Leibniz Association connects 97 independent research institutions that range in focus from natural, engineering, and environmental sciences to economics, spatial, and social sciences and the humanities. Leibniz Institutes address issues of social, economic, and ecological relevance. They conduct basic and applied research, including in the interdisciplinary Leibniz Research Alliances, maintain scientific infrastructure, and provide research-based services. The Leibniz Association identifies focus areas for knowledge transfer, particularly with the Leibniz research museums. It advises and informs policymakers, science, industry, and the general public. Leibniz institutions collaborate intensively with universities – including in the form of Leibniz ScienceCampi – as well as with industry and other partners at home and abroad. They are subject to a transparent, independent evaluation procedure. Because of their importance for the country as a whole, the Leibniz Association Institutes are funded jointly by Germany’s central and regional governments. The Leibniz Institutes employ around 20,500 people, including 11,500 researchers. The financial volume amounts to 2 billion euros. For more information: www.leibniz-gemeinschaft.de/en/.
Originalpublikation:
Publication
Samim Sharifi, Prerana Chaudhari, Asya Martirosyan, Alexander Otto Eberhardt, Finja Witt, André Gollowitzer, Lisa Lange, Yvonne Woitzat, Eberechukwu Maryann Okoli, Huahui Li, Norman Rahnis, Joanna Kirkpatrick, Oliver Werz, Alessandro Ori, Andreas Koeberle, Holger Bierhoff & Maria Ermolaeva. Reducing the metabolic burden of rRNA synthesis promotes healthy longevity in Caenorhabditis elegans. Nat Commun 15, 1702 (2024).
https://doi.org/10.1038/s41467-024-46037-w
Die semantisch ähnlichsten Pressemitteilungen im idw
